Back to
STATE STREET CORP
PTGX28 quarters
Position history for
STATE STREET CORP's holdings in PROTAGONIST THERAPEUTICS INC
Yes. State Street holds 3,321,554 shares of PTGX (Protagonist Therapeutics), worth $407.2M, as of its Q2 2026 13F filing. It increased the position by 204,805 shares (+6.6%) from Q1 2026. State Street has held PTGX in every 13F on record since Q3 2019, 28 quarterly filings.
Current Value
$407.2M
Current Shares
3.3M
Total Value Change
+$403.4M
Total Shares Change
+3M
Quarter-by-Quarter History
Other major holders of PTGX: BlackRock, Inc., FARALLON CAPITAL MANAGEMENT, L.L.C.